| Literature DB >> 24955930 |
Jayachandran Venkatesan1, Ratih Pangestuti2, Zhong-Ji Qian3, BoMi Ryu4, Se-Kwon Kim5.
Abstract
Phosphorylated chitooligosaccharides (P-COS) were prepared using a H3PO4, P2O5, Et3PO4 and hexanol solvent system. The P-COS were characterized by Fourier Transform Infrared Spectroscopy (FT-IR), Thermo gravimetric-Differential Thermal Analyzer (TG-DTA), 13C NMR, 31P NMR, X-ray diffraction analysis, solubility studies, biocompatibility and Alkaline Phosphatase Activity (ALP). The results reveal that phosphorylation occurred at the C3 and C6 position of OH groups and the C2 position of NH2 group. FT-IR confirmed no decomposition in pyranose ring in P-COS even with heating and treatment in acidic conditions. The amorphous nature of P-COS was confirmed by X-ray diffraction analysis. Further, the biocompatibility and alkaline phosphatase activity of P-COS were checked against the osteosarcoma MG63 cell line at different concentrations and no cytotoxicity was observed. After 12 h and 24 h of incubation, the ALP activity of P-COS was higher compared with the control group. These results suggest that P-COS is a biocompatible material and in future P-COS could open up a number of promising pharmaceutical and clinical applications to mankind.Entities:
Year: 2010 PMID: 24955930 PMCID: PMC4030895 DOI: 10.3390/jfb1010003
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Solubility of phosphorylated chitooligosaccharides (P-COS).
| Solvent | Chitooligosaccharides | P-Chitooligosaccharides |
|---|---|---|
| H2O | Soluble | Soluble |
| Acetic acid (1%) | Soluble | Soluble |
| NaOH (1%) | Soluble | Soluble |
| HCl (1%) | Soluble | Soluble |
| Dimethyl sulfoxide | Soluble | Soluble |
| Dimethyl acetamide | Insoluble | Insoluble |
| Pyridine | Swelling | Swelling |
| Dimethyl formamide | Insoluble | Insoluble |
| Ethanol | Insoluble | Insoluble |
| Acetone | Insoluble | Insoluble |
| Chloroform | Insoluble | Insoluble |
Figure 1FT-IR spectra of (a) Chitooligosaccharide (COS; red line) and (b) Phosphorylated chitooligosaccharide (P-COS; black line).
Figure 2TG-DTA curve of (a) TG-chitooligosaccharide (b) TG-P-chitooligosaccharide (c) DTA-Chitooligosaccharide (d) TG-P chitooligosaccharide.
Figure 3.13C NMR spectra of (a) chitooligosaccharide (COS), and (b) phosphorylated chitooligosaccharide (P-COS).
Figure 431P NMR spectra of S3—POS.
Figure 5Cytotoxicity effects of the phosphorylated chitooligosaccharides in the MG63 cell line. The error bar indicates the standard variation of three parallel experiments.
Figure 6Alkaline phosphatase activities at 12 and 24 h after treatment of osteoblast-like MG63cells with different molecular weight phosphorylated chitooligosaccharides (low conc. 10 μg/mL, high conc. 100 μg/mL). The error bars indicate the standard variation of three parallel experiments.